The company now expects adjusted earnings between $19.50 and $20 per share, surpassing previous guidance and analyst expectations. This optimistic outlook rests on the insurer’s ability to stabilize medical costs, a persistent challenge that has weighed on the industry in recent years.

Chief Executive Tim Noel attributed these gains to strategic shifts in benefit design, network curation, and revamped care-management models. Furthermore, the company anticipates Medicare Advantage enrollment will decline by approximately 1.1 million, a figure Noel characterized as better than earlier projections. Looking ahead to 2026, management expects Medicare medical costs to track lower than their initial estimates, providing a clearer path for sustained financial performance.